Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q3 FY19 results · Oct–Dec 2018
Dr. Lal Path Labs reported revenue from operations of ₹292.50 crore and net profit of ₹46.10 crore for Q3 FY19 (Oct–Dec 2018), on a consolidated basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 292.50 | — | — | 317.50 | −7.9% |
| Other income | 12.20 | — | — | 10.90 | +11.9% |
| Total income | 304.70 | — | — | 328.40 | −7.2% |
| Profit before tax | 67.90 | — | — | 88.10 | −22.9% |
| Net profit for the period | 46.10 | — | — | 57.40 | −19.7% |
| Attributable to shareholders of the company | 45.80 | — | — | 57.00 | −19.6% |
| EPS, basic (₹) | 5.56 | — | — | 6.92 | −19.7% |
| Net margin (%) | 15.8 | — | 18.1 |
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 282.80 | — | — | 307.20 | −7.9% |
| Other income | 11.90 | — | — | 10.70 | +11.2% |
| Total income | 294.70 | — | — | 317.90 | −7.3% |
| Profit before tax | 65.30 | — | — | 84.80 | −23.0% |
| Net profit for the period | 44.30 | — | — | 55.20 | −19.7% |
| EPS, basic (₹) | 5.38 | — | — | 6.71 | −19.8% |
| Net margin (%) | 15.7 | — | 18.0 |
Consolidated
- Filed with BSE
- 08 Feb 2019, 16:50 IST
- Board meeting
- 08 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Feb 2019, 16:50 IST
- Board meeting
- 08 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE